Publizoom

Samsung Bioepis NL B.V.

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won
7
Shared contracts
5 (multi-supplier framework agreements)
Period
1 September 2026 – 1 October 2026

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned endContractCurrent holderAmount
31 March 2029
re-tender around October 2028
Amgros 2027 1.1052.b
Amgros I/S framework agreement
Biocon Biologics Ireland Limited
Orion Pharma A/S
Pfizer ApS
Samsung Bioepis NL B.V.
Accord Healthcare AB
Roche Pharmaceuticals A/S
Orifarm A/S
Abacus Medicine A/S
2care4 ApS
5 bids received
–

Contracts won

DateContractBuyerAmount
01/10/2026 2026/0312-Concurso público internacional para aquisição de medicamentos Entidades do Serviço Nacional de Saúde €10,384,743
shared by 9
24/09/2026 Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Ranibizumab, ATC S01LA04 für die Zeit 01.09.2024 - 31.08.2026 DAK-Gesundheit €1
shared by 18
23/09/2026 2026/0429- Concurso público internacional para aquisição de medicamentos OUTRAS INSTITUIÇÕES DE SAÚDE €1,362,736
shared by 6
23/09/2026 Amgros 2027 1.1052.b Amgros I/S –
23/09/2026 Amgros 2027 1.1152.a Amgros I/S –
08/09/2026 Suministro respetuoso con el medio ambiente, de medicamentos bilógicos con biosimilares destinado a los centros del ámbito de la sanidad pública valenciana Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad €8,735,686,152
shared by 8
01/09/2026 Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Denosumab, ATC M05BX04 für die Zeit 01.07.2025 - 30.06.2026 (zzgl. Verlängerungsoption 1x 12 Monate) DAK-Gesundheit €1
shared by 22

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.